Peptides DB
Research-centric peptide and protocol reference hub
Study 20 of 21HMG (Human Menopausal Gonadotropin) literatureThe Lancet. Digital health · ReviewTop journal2026

Artificial intelligence models for automated and semiautomated analysis and interpretation of clinical electroencephalography.

AI is advancing in EEG interpretation, potentially enhancing diagnostic capabilities and reducing expert workload, but further clinical validation is needed.

Read at The Lancet. Digital healthAdd to compare

Where it sits

this study against the rest of the hmg (human menopausal gonadotropin) corpus
0
Preclinical
15
Observational
0
Open-label
3
Randomised
3
Reviews · this one

Summary and findings

The review discusses the application of artificial intelligence models for the automated and semi-automated analysis of clinical electroencephalography (EEG). It highlights AI's potential to augment human expertise in EEG interpretation, particularly in spike and seizure detection and data analysis from wearables and critically ill patients. The review summarizes recent research and development in AI-based EEG interpretation.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as The Lancet. Digital health supplied them

Electroencephalography is the most commonly used diagnostic tool for epilepsy. However, interpreting electroencephalograms (EEGs) requires expertise that is not widely available. Advances in digital technology and wearables have enabled large-scale EEG recording, generating vast amounts of data that cannot be managed through traditional visual interpretation by experts. Artificial intelligence (AI) has the potential to augment human expertise and reduce workloads. The application of artificial neural networks in analysing clinical EEG recordings has led to major breakthroughs, bringing AI-based EEG interpretation closer to clinical implementation. In this Review, we summarise the most important research and development results in this field from a clinical perspective. We provide an overview of AI applications in spike and seizure detection; analysis of data from wearable electroencephalographs, patients who are critically ill, and epilepsy surgery; and the automated interpretation of clinical EEGs.

Background

Electroencephalography (EEG) is a critical diagnostic tool for epilepsy, but its interpretation requires specialized expertise that is not universally accessible. With the advent of digital technology and wearable devices, EEG data collection has expanded significantly, necessitating new methods for data interpretation. This review addresses the potential of artificial intelligence (AI) to enhance EEG analysis, a topic of growing importance given the increasing volume of EEG data.

Methods

Not reported in abstract.

Results

The review highlights the application of artificial neural networks in EEG analysis, noting significant advancements in AI-based interpretation. It discusses AI's role in detecting spikes and seizures, analyzing data from wearable devices, and interpreting EEGs from critically ill patients and those undergoing epilepsy surgery. The review emphasizes AI's progress towards clinical implementation.

Interpretation

The review suggests that AI models have made significant progress in EEG interpretation, potentially reducing the workload on human experts. However, the lack of specific quantitative data in the review limits the ability to assess the clinical significance of these advancements. The findings align with existing literature on AI's potential in medical diagnostics but require further validation through clinical trials.

Key findings

  • AI models can augment human expertise in EEG interpretation.
  • AI applications include spike and seizure detection.
  • AI is used in analyzing data from wearable EEG devices.
  • AI aids in the interpretation of EEGs from critically ill patients.
  • AI is moving towards clinical implementation for EEG analysis.

Limitations

  • No new experimental data presented.
  • Lacks specific quantitative findings.
  • Focuses on summarizing existing research.
  • No clinical trial data included.

Elsewhere in the HMG (Human Menopausal Gonadotropin) corpus

BDelayed Argon Plasma Coagulation After Endoscopic Injection Sclerotherapy for Esophageal Varices Reduces Recurrence Risk.DEN open · 2026 · n=112 · 3-year variceal recurrence: 13.9% outpatient vs 28.0% inpatient, p=0.039HumanBSomatic Mosaic &lt;i&gt;AXIN2&lt;/i&gt;-associated Colonic Polyposis Predominantly Involving the Proximal Colon: A Case Report.DEN open · 2023 · n=1 · Not reported in abstract.HumanDSex-specific reproductive and hormonal factors in relation to Alzheimer’s disease-related biomarkers: A Systematic Reviewbiorxiv-preprint · 2026 · Not reported in abstract.reviewBComparison between the efficacy of short and long GnRH-a protocols as a clinical outcome for viable pregnancies in women undergoing IVF/ICSI Cycles.biorxiv-preprint · 2021 · Clinical pregnancy rates: LAP 33.12% vs SAP 28.23%, p=0.001.HumanBRecombinant Follicular Stimulating Hormone Plus Recombinant Luteinizing Hormone Versus Human Menopausal Gonadotropins- Does the Source of LH Bioactivity Affect Ovarian Stimulation Outcome?biorxiv-preprint · 2021 · Mean number of mature oocytes retrieved: 10 ± 5.8 in rFSH+rLH vs 8.3 ± 4.6 in HP-hMG, p=0.01.HumanBUsing Letrozole Cotreatment With Progestin-Primed Ovarian Stimulation In Women With Polycystic Ovary Syndrome Treated For IVFbiorxiv-preprint · 2021 · 42.22% implantation rate in letrozole group vs. 34.69% in control group, p<0.05Human